Abiopharma

🔍 Schafer Douglas M. JR (Executive)

Company: MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX)

Report Date: 2026-05-04

Detailed Transactions and Holdings:

• Acquired 48,000 shares of Common Stock at $12.0 per share (Direct)
  Date: 2026-05-04 | Code: M | equity_swap_involved: 0 | shares_owned_after: 444,681.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 48,000 shares of Common Stock at $47.25 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 396,681.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 48,000 shares of Nonqualified Stock Option (Right to Buy) at $12.0 per share (Derivative)
  Date: 2026-05-04 | Code: M | Expires: 2026-08-02 | equity_swap_involved: 0 | shares_owned_after: 54,000.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: This transaction was effected pursuant to a previously established Rule 10b5-1 Plan adopted by the Reporting Person on December 16, 2025.
• F2: This transaction was executed in multiple trades throughout the day at prices ranging from $46.80 to $47.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
• F3: The options are fully vested.